Gold price takes top spot as the precious metal jumps 8.12% higher amidst on-going uncertainties clouding the global financial markets. The rapid spread of the Covid-19 virus continues to hold many Asian economies back. India, who has been plagued by record high cases, ended the month as the strongest performer in the Asian bloc. Strong performance from metal and energy stocks pushed the SENSEX 9.58% higher in MYR terms. China’s broader equity market also enjoyed a strong run (7.5% gain) during the month as encouraging economic data boosted investors’ sentiment. The same however, was not felt in Malaysia, where rising infection numbers led to another Movement Control Order, halting economic activities for the 3rd time.
In the News
- The US markets ended the month of May near all-time highs as risk appetite for US equities returned on hopes for a full economic recovery.
- To date, around 52% of the population in the US has received at least one shot of the COVID-19 vaccine, while 42% of people in the US is now fully vaccinated.
- Technology stocks underperformed the broader market in May, as investors transitioned into recovery plays. The broader S&P gained 1.61%, while the tech-focused Nasdaq dipped 0.5%, and the FANG+ Index slid 1.47% in MYR terms. The 0831EA, which provides -100% exposure into the index, gained from the weaker performance of the Index, and saw its NAV rise 1.68% last month.
- In China, the broader market outperformed its US counterparts, with the Shanghai Composite Index and the CSI 300 Index gaining 7.53% and 6.67% in MYR terms respectively.
- However, the S&P New China Sectors ex-A index lagged behind the broader market, as the central government’s crackdown on tech companies extended from the original tech giants Alibaba and Tencent, onto Pinduoduo and Meituan Dianping.
- As a result, the index recorded a dip of 0.75% in MYR terms last month, leaving the 0829EA with a YTD loss of 0.04% in MYR terms.
- Outside China, the sentiment in Asia was drastically different from its western counterparts, as various Asia Pacific countries faced a record-breaking surge in COVID-19 infections.
- In Malaysia, the Full Movement Control Order (FMCO) was introduced to curb sky high infection rates, which surpassed India in infections per capita.
- Concerns of rising case numbers saw the local bourse underperforming its regional peers, as the FBM KLCI index dipped 1.13%, while the Dorsey Wright Malaysia Technical Leaders Index dipped by 3.11%, leaving the 0836EA sliding3.3% lower over the month.
- With concerns looming over global financial markets, Gold price enjoyed a bull run in May. Gold outperformed equities as the weaker dollar performance and inflationary concerns brought the precious yellow metal near a five-month high.
- In May, the LBMA Gold Price Index jumped of 8.12% in MYR terms, while the 0828EA, which tracks the index gained 7.84% in MYR terms throughout the month.
On the Economic Data Front
- US economic data shows mixed recovery
- Inflation rates in April accelerated to its fastest rate in over 12 years, with CPI rising 4.2% from a year earlier.
- Federal Reserve policy makers have deemed the spike as transitionary, with expectations that rates will fall to 2% later this year. Fedsassured that action would be taken if proven otherwise.
- 559,000 jobs were added in May, below consensus of 650,000; while employment-to-population ratio ticked higher.
- China’s economic stability faces challenges
- Inflationary pressures were felt strongly as measures for both input costs and the prices service providers charged rose to their highest points of the year.
- Manufacturing PMI rose to 52.0 last month, the highest level since December, up from April's 51.9.
- Services PMI fell to 55.1 in May, down from 56.3 in April but still well in expansionary territory.
A look at the performance of TradePlus ETFs,and major global indices
Learn more about TradePlus ETFs
Disclaimer: This article has been prepared by Affin Hwang Asset Management Berhad (hereinafter referred to as “Affin Hwang AM”) specific for its use, a specific target audience, and for discussion purposes only. All information contained within this presentation belongs to Affin Hwang AM and may not be copied, distributed or otherwise disseminated in whole or in part without written consent of Affin Hwang AM. The information contained in this presentation may include, but is not limited to opinions, analysis, forecasts, projections and expectations (collectively referred to as “Opinions”). Such information has been obtained from various sources including those in the public domain, are merely expressions of belief. Although this presentation has been prepared on the basis of information and/or Opinions that are believed to be correct at the time the presentation was prepared, Affin Hwang AM makes no expressed or implied warranty as to the accuracy and completeness of any such information and/or Opinions. As with any forms of financial products, the financial product mentioned herein (if any) carries with it various risks. Although attempts have been made to disclose all possible risks involved, the financial product may still be subject to inherent risk that may arise beyond our reasonable contemplation. The financial product may be wholly unsuited for you, if you are adverse to the risk arising out of and/or in connection with the financial product. Affin Hwang AM is not acting as an advisor or agent to any person to whom this presentation is directed. Such persons must make their own independent assessments of the contents of this presentation, should not treat such content as advice relating to legal, accounting, taxation or investment matters and should consult their own advisers. Affin Hwang AM and its affiliates may act as a principal and agent in any transaction contemplated by this presentation, or any other transaction connected with any such transaction, and may as a result earn brokerage, commission or other income. Nothing in this presentation is intended to be, or should be construed as an offer to buy or sell, or invitation to subscribe for, any securities. Neither Affin Hwang AM nor any of its directors, employees or representatives are to have any liability (including liability to any person by reason of negligence or negligent misstatement) from any statement, opinion, information or matter (expressed or implied) arising out of, contained in or derived from or any omission from this presentation, except liability under statute that cannot be excluded.
Warning Statement: A copy of the Prospectus / Supplemental Prospectus for the TradePlus Shariah Gold Tracker and TradePlus S&P New China Tracker, the Prospectus for the TradePlus DWA Malaysia Momentum Tracker and TradePlus MSCI Asia Ex Japan REITs Tracker, as well as the Master Prospectus for the TradePlus NYSE® FANG+™ Daily (2x) Leveraged Tracker, TradePlus NYSE® FANG+™ Daily (-1x) Inverse Tracker, TradePlus HSCEI Daily (2x) Leveraged Tracker and TradePlus HSCEI Daily (-1x) Inverse Tracker (collectively known as the “TradePlus L&I ETFs”) can be obtained at Affin Hwang Asset Management's (“Affin Hwang AM”) website at www.tradeplus.com.my. Investors are advised to read and understand the contents of the Prospectus dated 28 November 2017 and Supplemental Prospectus dated 2 July 2019 (for TradePlus Shariah Gold Tracker), Prospectus dated 15 January 2019 and Supplemental Prospectus dated 2 July 2019 (for TradePlus S&P New China Tracker), Prospectus dated 9 July 2020 (for TradePlus DWA Malaysia Momentum Tracker), Prospectus dated 9 July 2020 (for TradePlus MSCI Asia Ex Japan REITs Tracker), as well as the Master Prospectus dated 26 November 2019 (for the TradePlus L&I ETFs) before investing. There are fees and charges involved when investing in the funds stated herein. Investors are advised to consider and compare the fees and charges as well of the risks carefully before investing. Investors should make their own assessment of the risks involved in investing and should seek professional advice, where necessary. The price of units and distribution payable, if any, may go down as well as up and past performance of the funds should not be taken as indicative of their future performance. The Securities Commission Malaysia has not reviewed this material and takes no responsibility for the contents of this material and expressly disclaims all liability, however arising from this material.
You may refer to the relevant Licensing Disclosure Statement & Conditions at the respective webpages for each fund available on www.tradeplus.com.my.